Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands
Clinical trial NCT01273597 · COMPLETED
Trial details
- NCT number
- NCT01273597
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.